Linkage modified oligomeric compounds and uses thereof
US-12595482-B2 · Apr 7, 2026 · US
This page is not indexed by search engines while we improve data quality.
Oestergaard Michael patents
Oestergaard Michael is listed as an inventor on 63 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Oestergaard Michael |
| Total patents | 63 |
| First publication | Oct 1, 2015 |
| Latest publication | Apr 7, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Selective Antisense Compounds and Uses Thereof
US-2025376683-A1 · Dec 11, 2025 · US
Linkage Modified Oligomeric Compounds and Uses Thereof
US-2025368995-A1 · Dec 4, 2025 · US
Modified Compounds and Uses Thereof
US-2025354135-A1 · Nov 20, 2025 · US
Conjugated Antisense Compounds and Their Use
US-2025333741-A1 · Oct 30, 2025 · US
Selective Antisense Compounds and Uses Thereof
US-2025270554-A1 · Aug 28, 2025 · US
Compounds and methods for reducing dmpk expression
US-2025177433-A1 · Jun 5, 2025 · US
Linkage modified oligomeric compounds and uses thereof
US-2025154506-A1 · May 15, 2025 · US
Conjugated antisense compounds and their use
US-12275940-B2 · Apr 15, 2025 · US
Modified compounds and uses thereof
US-12234447-B2 · Feb 25, 2025 · US
Recent patents
Latest publications not already listed above.
Selective antisense compounds and uses thereof
US-12152244-B2 · Nov 26, 2024 · US
Conjugated oligonucleotides and uses thereof
US-2024382605-A1 · Nov 21, 2024 · US
Selective Antisense Compounds and Uses Thereof
US-2024368592-A1 · Nov 7, 2024 · US
Allele-selective compounds and methods for modulating huntingtin expression
US-2024325425-A1 · Oct 3, 2024 · US
Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
US-2024293563-A1 · Sep 5, 2024 · US
Selective Antisense Compounds and Uses Thereof
US-2024294923-A1 · Sep 5, 2024 · US
Conjugated antisense compounds and their use
US-2024279664-A1 · Aug 22, 2024 · US
Selective Antisense Compounds and Uses Thereof
US-2024141343-A1 · May 2, 2024 · US
Linkage modified oligomeric compounds and uses thereof
US-2024002851-A1 · Jan 4, 2024 · US
Selective antisense compounds and uses thereof
US-11732261-B2 · Aug 22, 2023 · US
Conjugated antisense compounds and their use
US-11725208-B2 · Aug 15, 2023 · US
Linkage modified oligomeric compounds and uses thereof
US-11629348-B2 · Apr 18, 2023 · US
Selective Antisense Compounds and Uses Thereof
US-2023113863-A1 · Apr 13, 2023 · US
Modified Compounds and Uses Thereof
US-2023068063-A1 · Mar 2, 2023 · US
Selective antisense compounds and uses thereof
US-2023002763-A1 · Jan 5, 2023 · US
Linkage modified oligomeric compounds and uses thereof
US-2022186222-A1 · Jun 16, 2022 · US
Modified compounds and uses thereof
US-11332733-B2 · May 17, 2022 · US
Selective antisense compounds and uses thereof
US-11236335-B2 · Feb 1, 2022 · US
Conjugated antisense compounds and their use
US-2022023429-A1 · Jan 27, 2022 · US
Chirally enriched oligomeric compounds
US-2021380976-A1 · Dec 9, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ionis Pharmaceuticals Inc | 60 |
| Isis Pharmaceuticals Inc | 4 |
| Seth Punit P | 2 |
| Oestergaard Michael | 2 |
| Swayze Eric E | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/315 | 63 |
| C12N2310/3231 | 61 |
| C12N2310/11 | 57 |
| C12N2310/341 | 57 |
| C12N15/113 | 54 |